GGrantIndex
← Leaderboards

Faramarz Ismail-Beigi

Case Western Reserve University

$6,031,516
Attributed
$13,807,364
Total exposure
10
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.4M · FY200524
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$13,807,364 · 10

By mechanism

R01$12,696,787 · 8
P01$865,040 · 1
N01$245,537 · 1

Most similar at Case Western Reserve University

Same institution · by research overlap

Others in their field

Top investigators on “Diabetes Mellitus

Research focus

Diabetes MellitusNon-Insulin-Dependent Diabetes MellitusInsulinRattusStreptozocinAnimalsBaseDesignStructureInterdisciplinary ApproachSafetyMolecular ConformationFormulationHormonesProtein EngineeringPumpInsulin-Dependent Diabetes MellitusBindingMolecularInsulin ReceptorAnalogPropertySeriesIn Vivo

Grant awards (32)

Non-Standard Protein Design in Molecular Endocrinology: Insulin and Glucagon$582,675
R01 · FY2024 · DK
Non-Standard Protein Design in Molecular Endocrinology: Insulin and Glucagon$606,952
R01 · FY2023 · DK
Non-Standard Protein Design in Molecular Endocrinology: Insulin and Glucagon$621,554
R01 · FY2022 · DK
Molecular endocrinology and principles of diabetes therapeutics: application to ultra-stable insulin analogs$619,708
R01 · FY2022 · DK
Therapeutic Protein Engineering of Single-Chain Insulin Analogs$532,042
R01 · FY2022 · DK
Molecular engineering of complementary glucose-responsive conformational switches in insulin and glucagon$490,285
R01 · FY2022 · DK
Non-Standard Protein Design in Molecular Endocrinology: Insulin and Glucagon$623,425
R01 · FY2021 · DK
Molecular endocrinology and principles of diabetes therapeutics: application to ultra-stable insulin analogs$619,708
R01 · FY2021 · DK
Molecular engineering of complementary glucose-responsive conformational switches in insulin and glucagon$583,648
R01 · FY2021 · DK
Therapeutic Protein Engineering of Single-Chain Insulin Analogs$531,394
R01 · FY2021 · DK
Molecular endocrinology and principles of diabetes therapeutics: application to ultra-stable insulin analogs$647,357
R01 · FY2020 · DK
Molecular engineering of complementary glucose-responsive conformational switches in insulin and glucagon$631,349
R01 · FY2020 · DK
Non-Standard Protein Design in Molecular Endocrinology: Insulin and Glucagon$625,785
R01 · FY2020 · DK
Therapeutic Protein Engineering of Single-Chain Insulin Analogs$531,944
R01 · FY2020 · DK
Therapeutic Protein Engineering of Single-Chain Insulin Analogs$535,684
R01 · FY2019 · DK
Therapeutic Protein Engineering of Single-Chain Insulin Analogs$554,879
R01 · FY2018 · DK
Novel PET Imaging of Glucose Transport$334,680
R01 · FY2012 · DK
Novel PET Imaging of Glucose Transport$334,680
R01 · FY2011 · DK
Novel PET Imaging of Glucose Transport$373,032
R01 · FY2010 · DK
ACCORD$245,537
N01 · FY2010 · HL · contact PI
Novel PET Imaging of Glucose Transport$376,800
R01 · FY2009 · DK
Carbohydrate Metabolic Pathways$435,423
R01 · FY2007 · DK · contact PI
THYROIDAL REGULATION OF CARDIAC SODIUM/POTASSIUM ATPASE EXPRESSION AND ENERGETICS$262,221
P01 · FY2006 · HL · contact PI
Regulation of Glut 1 Function$242,785
R01 · FY2006 · DK · contact PI
THYROIDAL REGULATION OF CARDIAC SODIUM/POTASSIUM ATPASE EXPRESSION AND ENERGETICS$254,583
P01 · FY2005 · HL
Regulation of Glut 1 Function$248,628
R01 · FY2005 · DK
Regulation of Glut 1 Function$248,628
R01 · FY2004 · DK
Regulation of Glut 1 Function$325,125
R01 · FY2003 · DK
THYROIDAL REGULATION OF CARDIAC SODIUM/POTASSIUM ATPASE EXPRESSION AND ENERGETICS$174,118
P01 · FY2002 · HL
REGULATION OF GLUT1 GENE EXPRESSION BY HYPOXIA$222,549
R01 · FY2001 · DK
REGULATION OF GLUT1 GENE EXPRESSION BY HYPOXIA$216,068
R01 · FY2000 · DK
THYROID HORMONE CONTROL OF CARDIAC SODIUM/POTASSIUM ATPASE EXPRESSION$174,118
P01 · FY2000 · HL